Companies / Beam Therapeutics Inc.

Beam Therapeutics Inc.

Nasdaq: BEAMCIK 1745999CAMBRIDGE, MA

Financials · FY2025

Revenue$139.74M
Net income$-79.99M
Total debt$100.26M
Cash$219.82M
Diluted EPS$-0.81
Shares outstanding103.3M

Ownership

103.3M shares outstanding · as of Jul 28, 2026
1.4%Insiders
Ownership
Insiders1.41%1,458,433
10%+ / strategic17.41%17,978,898
Institutions87.32%90,191,066
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Evans John M.CEOCEO · Director
0.96%986,667
Ciaramella GiuseppePresident
0.18%190,216
Bellon ChristineChief Legal Officer
0.09%95,667
Simon AmyChief Medical Officer
0.07%77,364
Emany Sravan KumarChief Financial Officer
0.07%73,706
Cavanagh Bethany JSVP, Finance and Treasurer
0.03%34,813
Cooper Graham KDirector
——
Maraganore JohnDirector
——

Institutional holders 254

View all →
HolderValue% of shares
ARK Investment Management LLC$345.59M12.07%
Fmr LLC$330.12M11.53%
BlackRock, Inc.$308.80M8.71%
Farallon Capital Management LLC$278.95M9.74%
Vanguard Group Inc$254.84M8.90%
State Street Corporation$199.99M5.64%
Sumitomo Mitsui Trust Group, Inc.$122.23M4.27%
Amova Asset Management Americas, Inc.$122.18M4.27%
ARCH Venture Management, LLC$108.19M4.40%
Kynam Capital Management, LP$67.64M2.36%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 24, 2026Ciaramella Giuseppe
Executive
SellCommon Stock$1.12M-35K
-15.54%
190,216
0.18% of shares
medium
Jan 30, 2026Evans John M.
CEO
SellCommon Stock$624.7K-22K
-2.18%
989,573
0.96% of shares
medium
Feb 24, 2026Ciaramella Giuseppe
Executive
ExerciseCommon Stock$595.0K+35K
+18.40%
225,216
0.22% of shares
low
Jan 15, 2026Bellon Christine
Executive
SellCommon Stock$554.1K-16K
-14.05%
97,597
0.09% of shares
medium
Jan 29, 2026Evans John M.
CEO
SellCommon Stock$476.8K-16K
-1.61%
995,334
0.96% of shares
medium
Jan 29, 2026Evans John M.
CEO
SellCommon Stock$257.8K-9K
-0.87%
986,667
0.96% of shares
medium
Jan 22, 2026Cavanagh Bethany J
Executive
SellCommon Stock$216.9K-6K
-15.11%
34,813
0.03% of shares
medium
Dec 31, 2025Emany Sravan Kumar
Executive
SellCommon Stock$170.6K-6K
-7.87%
73,706
0.07% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Farallon Capital Partners, L.P.Passive13G/A———
ARK Investment Management LLCPassive13G/A———
Fmr LLCPassive13G/A—12,750,369—
State Street CorporationPassive13G—5,228,529—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BEAM——07373V105—